KMK.L

Kromek Group Plc
Kromek Group PLC - Kromek selected for UK Government Framework
30th July 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2920Y
Kromek Group PLC
30 July 2024
 

30 July 2024

 

Kromek Group plc

("Kromek" or the "Group")

 

Kromek selected for UK Government Resilience Framework

First order received under the framework from Merseyside Fire & Rescue Service

 

Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that its D3M detector has been named as the Personal Radiation Detector ("PRD") under the UK Government Resilience Framework (the "Framework"). The Group has received its first order under the Framework from Merseyside Fire & Rescue Service, which will use the D3M for its Detection, Identification and Monitoring ("DIM") vehicles.  

 

The Framework is designed to strengthen the UK's resilience system to prevent risks manifesting or crises happening where possible, addressing all serious threats to public safety and security. It focuses on the foundational building blocks of resilience, setting out a plan to 2030 to strengthen the frameworks, systems and capabilities that underpin the UK's resilience to all civil contingencies risks.  

 

The D3M is the only PRD that has been pre-approved for purchase under the Framework, which is scheduled to be in place for four years. As a result, all blue light service operators in the UK, such as fire, police, ambulances and first responders, can purchase the D3M detector for projects under the Framework without going through a separate approval process.

 

Merseyside Fire & Rescue service have bought the D3M under their Detection, Identification and Monitoring (DIM) Equipment Uplift project, which involves acquiring equipment to enhance their capabilities for detection of Chemical, Biological, Radiological, and Nuclear ("CBRN") threats.

 

Arnab Basu, CEO of Kromek, said: "We are delighted that our D3M detector has been named as the only PRD under this significant UK initiative and to have received our first order from Merseyside Fire & Rescue Service. The D3M is a world-leading radiation detector that offers unprecedented situational awareness. Being selected for this framework is another validation of the strength of our solutions and opens up another important commercial avenue for our CBRN products. We look forward to supporting Merseyside Fire & Rescue Service and other emergency service operators in identifying potential radiological threats and keeping people safe."

 

 

For further information, please contact:

 

Kromek Group plc 


Arnab Basu, CEO 

Paul Farquhar, CFO 

+44 (0)1740 626 060

 


Cavendish Capital Markets Limited (Nominated Adviser and Broker) 

 

Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance 

Tim Redfern - ECM 

+44 (0)20 7220 0500 

 

Michael Johnson/Tamar Cranford-Smith - Sales

 


Gracechurch Group (Financial PR) 


Harry Chathli/Claire Norbury/Henry Gamble

+44 (0)20 4582 3500

 

 

Kromek Group plc 

 

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.  

 

The advanced imaging segment comprises the medical, security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.  

 

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defense and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of 'dirty bombs'.  

 

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.  

 

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.  

 

Further information is available at www.kromek.com. 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAEXNADELEAA]]>
TwitterFacebookLinkedIn